NCT00574951 2018-01-11AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerGOG FoundationPhase 2 Terminated23 enrolled 9 charts
NCT00369070 2018-01-04A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLCAmgenPhase 2 Terminated186 enrolled
NCT00356681 2015-10-15A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast CancerAmgenPhase 2 Terminated282 enrolled
NCT00360867 2015-10-15An Open Label Treatment Extension Study of AMG 706AmgenPhase 2 Terminated94 enrolled